國藥一致(000028.SZ):國大藥房成功摘牌成大方圓100%股權轉讓項目 成交價18.6億元
格隆匯 7 月 24日丨國藥一致(000028.SZ)公佈,遼寧成大將其持有的成大方圓醫藥集團有限公司(以下簡稱“成大方圓”或“標的公司”)100%股權在大連產權交易所公開掛牌轉讓,公開掛牌轉讓底價為186,000萬元人民幣。
2020年7月24日,國大藥房已成功摘牌成大方圓100%股權轉2020年7月20日,國藥集團一致藥業股份有限公司召開第八屆董事會第十八次會議,審議通過了《關於國藥控股國大藥房有限公司擬摘牌收購成大方圓醫藥集團有限公司100%股權的議案》,同意國藥控股國大藥房有限公司(以下簡稱“國大藥房”)辦理進場摘牌事宜。
2020年7月24日,國大藥房已成功摘牌成大方圓100%股權轉讓項目,成交價格為人民幣186,000萬元。同日,國大藥房與遼寧成大簽署了《產權交易合同》。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.